期刊文献+

噻托溴胺吸入治疗慢性阻塞性肺疾病稳定期临床观察 被引量:1

下载PDF
导出
摘要 目的观察噻托溴胺对慢性阻塞性肺疾病(COPD)稳定期的治疗效果。方法将60例COPD稳定期Ⅲ—Ⅳ级患者随机分成2组,每组30人,试验组使用噻托溴胺粉吸入剂吸入治疗,对照组口服氨茶碱治疗,疗程均为3月,以治疗前后肺功能指标及6 min步行距离(6MWD)为观察指标。结果经3月治疗后,对照组治疗前后FEV1、FEV1%、FEV1/FVC、6MWD比较差异无统计意义(P>0.05);试验组治疗前后FEV1、FEV1%、FEV1/FVC、6MWD比较及2组治疗后各项指标比较,差异有高度统计意义(P<0.01)。结论噻托溴胺吸入治疗能够改善慢性阻塞性肺疾病稳定期Ⅲ—Ⅳ级患者肺功能及6MWD。
出处 《甘肃中医学院学报》 2010年第3期38-40,共3页 Journal of Gansu College of Traditional Chinese Medicine
  • 相关文献

参考文献8

  • 1慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量:5103
  • 2Tashkin D P, Cooper C B . The role of long-acting bronchodilators in the management of stable COPD [ J ]. Chest , 2004,125 : 249 - 259.
  • 3IVan Noord J A, Bantje TA, Eland M E, et al. A randomized controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease [ J ]. Thorax, 2000,55 (4) : 289 - 294.
  • 4Lubinski W. Tiotropium as a controller of broncho constriction[ J ]. Pol Merkur Lekarski, 2004, 16 ( supplel ) : 75 - 76.
  • 5Keam S J, Keating G M. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD [ J ].Treat Respir Med, 2004,3 ( 4 ) : 247 - 268.
  • 6Oostenbrink J B, Rutten-van molken MPMH, Al M J, et al. One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease [ J ]. Eur Respir J,2004,23 (2) : 241 - 249.
  • 7马艳良,何权瀛.步行试验对慢性阻塞性肺疾病患者的意义[J].中华结核和呼吸杂志,2007,30(9):699-701. 被引量:14
  • 8Pinto-Plata V M, Cote C, Cabral H, et al. The 6-min walk distance : change over time and value as a predictor of survival in severe COPD [ J]. Eur Respir J,2004,23 ( 1 ) : 28 - 33.

二级参考文献23

  • 1刘升明,王小平,王大礼,周玉民,吕嘉春,郑劲平,钟南山,冉丕鑫.广东部分地区慢性阻塞性肺疾病发病状况调查[J].中华医学杂志,2005,85(11):747-752. 被引量:150
  • 2姚婉贞,朱红,沈宁,韩翔,梁岩静,张立强,孙永昌,郝振婷,赵鸣武.北京市延庆县慢性阻塞性肺疾病流行病学调查结果[J].北京大学学报(医学版),2005,37(2):121-125. 被引量:55
  • 3ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med, 2002,166: 111- 117.
  • 4McGavin CR, Gupta SP, McHardy GJ. Twelve-minute walking test for assessing disability in chronic bronchitis. Br Med J, 1976, 1:822-823.
  • 5Butland RJ, Pang J, Gross ER, et al. Two-, six, and 12-minute walking tests in respiratory disease. Br Med J, 1982, 284 : 1607- 1608.
  • 6Solway S, Brooks D, Lacasse Y, et al. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest, 2001,119:256-270.
  • 7Enright PL, Sherrill DL. Reference equations for the fix-minute walk in healthy adults. Am J Respir Crit Care Med, 1998,158 (5 Pt 1) :1384-1387.
  • 8Stevens D, Elpem E, Sharma K, et al. Comparison of hallway and treadmill six-minute walk tests. Am J Respir Crit Care Med, 1999,160(5 Pt 1) :1540-1543.
  • 9Guyatt GH, Pugsley SO, Sullivan MJ, et al. Effect of encouragement on walking test performance. Thorax, 1984, 39 : 818-822.
  • 10Leach RM, Davidson AC, Chinn S, et al. Portable liquid oxygen and exercise ability in severe respiratory disability. Thorax, 1992, 47:781-789.

共引文献5114

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部